21. 4-Hydroxy-tamoxifen-loaded liposomes have potent anti-myeloma activity. Issue 8 (August 2013) Authors: Urbinati, Giorgia; Marsaud, Véronique; Renoir, Jack-Michel; Sola, Brigitte Journal: Leukemia & lymphoma Issue: Volume 54:Issue 8(2013:Aug.) Page Start: 1808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. 5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells. Issue 10 (October 2014) Authors: Lalic, Hrvoje; Dembitz, Vilma; Lukinovic-Skudar, Vesna; Banfic, Hrvoje; Visnjic, Dora Journal: Leukemia & lymphoma Issue: Volume 55:Issue 10(2014:Oct.) Page Start: 2375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice. Issue 4 (3rd April 2017) Authors: Wong-Sefidan, Ida; Byrtek, Michelle; Zhou, Xiaolei; Friedberg, Jonathan W.; Flowers, Christopher R.; Zelenetz, Andrew D.; Dawson, Keith L.; Reid, Erin Journal: Leukemia & lymphoma Issue: Volume 58:Issue 4(2017) Page Start: 809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. [18F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma. Issue 1 (2nd January 2023) Authors: Vergote, Vibeke K. J.; Verhoef, Gregor; Janssens, Ann; Woei-A-Jin, F. J. Sherida H.; Laenen, Annouschka; Tousseyn, Thomas; Dierickx, Daan; Deroose, Christophe M. Journal: Leukemia & lymphoma Issue: Volume 64:Issue 1(2023) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. A "PET" topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end. Issue 1 (January 2015) Authors: Vassilakopoulos, Theodoros P.; Pangalis, Gerassimos A.; Polliack, Aaron Journal: Leukemia & lymphoma Issue: Volume 56:Issue 1(2015:Jan.) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. A 10-color flow cytometry panel for diagnosis and minimal residual disease in chronic lymphocytic leukemia. Issue 10 (24th August 2021) Authors: Bazinet, Alexandre; Rys, Ryan N.; Barry, Amadou; Greenwood, Celia M. T.; Young, Yoon Kow; Mendoza, Alma; LaPorta, Ida; Wever, Claudia M.; Mercier, François E.; Johnson, Nathalie A. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 10(2021) Page Start: 2352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Issue 13 (10th November 2021) Authors: Sweet, Kendra; Bhatnagar, Bhavana; Döhner, Hartmut; Donnellan, Will; Frankfurt, Olga; Heuser, Michael; Kota, Vamsi; Liu, Hongtao; Raffoux, Emmanuel; Roboz, Gail J.; Röllig, Christoph; Showel, Margaret M.; Strickland, Stephen A.; Vives, Susana; Tang, Shijie; Unger, Thaddeus J.; Joshi, Anita; Shen,... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 13(2021) Page Start: 3192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia. Issue 10 (3rd October 2018) Authors: Torrebadell, Montserrat; Díaz-Beyá, Marina; Kalko, Susana G.; Pratcorona, Marta; Nomdedeu, Josep; Navarro, Alfons; Gel, Bernat; Brunet, Salut; Sierra, Jorge; Camós, Mireia; Esteve, Jordi Journal: Leukemia & lymphoma Issue: Volume 59:Issue 10(2018) Page Start: 2394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy. Issue 12 (December 2014) Authors: O'Reilly, Maeve A.; McHale, Cathy; Almazmi, Ahmed; Hameed, Abdul; Benjamin, Dalia; O'Connell, Niamh; Murphy, Philip; Quinn, John; Thornton, Patrick; O'Gorman, Peter; Frankova, Hana; Sargent, Jeremy; Verburgh, Estelle; McHugh, John; Evans, Pamela; Enright, Helen Journal: Leukemia & lymphoma Issue: Volume 55:Issue 12(2014:Dec.) Page Start: 2950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial. Issue 7 (6th June 2020) Authors: Grosicki, Sebastian; Lech-Maranda, Ewa; Govind Babu, Kanakasetty; Rybka, Justyna; Litvinskaya, Elena; Loscertales, Javier; Kriachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Blonski, Jerzy; Stefanelli, Tommaso; Vincent, Ghislaine; Banerjee, Hiya; Robak, Tadeusz Journal: Leukemia & lymphoma Issue: Volume 61:Issue 7(2020) Page Start: 1748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗